Rubedo Life Sciences

This week in Milan a key event for the Longevity Medicine field is taking place all over the town: the Milan Longevity Summit. A 10 days collection of events focused on Longevity at 360 degrees: from science to education, from finance. I am excited to speak in the panel discussing Investment in Longevity and how to finance the future of medicine on March 26th, The Day Program is titled "Longevity Codes". Rubedo Life Sciences is strategic partner of the event. Hope to see you there! Thanks to Aeon Foundation, Niccolò Invidia, Nicola Marino and their team for leading the effort in organizing such an important event for Italy and the global field.

Ten Levels of Longevity: #8 systemic aging reversal Therapeutic interventions that stop or reverse age-related damage throughout the whole body system. Mitrix.bio Turn Biotechnologies Rubedo Life Sciences M Ventures Zoe Biosciences CELLAAX StarkAge Therapeutics #economy

?? The Future of Aging: Can We Reverse Time? My scale says I’m 12 years old. Science—and my 47-year-old body—might disagree. ?? But what if aging wasn’t inevitable? What if we could slow it down—or even reverse it? That’s exactly what I explored with Marco Quarta, longevity scientist & co-founder of Rubedo Life Sciences. His team is tackling one of aging’s biggest culprits: senescent cells (aka “zombie cells”)—which refuse to die and accelerate disease. ?? What’s coming next? ?? Targeted longevity treatments—Eliminating zombie cells to reduce inflammation & extend healthspan ?? Aging biomarkers—Tests that reveal your biological age before symptoms appear ??? Regulatory change—Aging isn’t yet classified as a disease, slowing innovation. That could soon shift. ?? Big picture—This isn’t just about looking younger. It’s about preventing our healthcare system from collapsing under an aging population. The bottom line? Aging doesn’t have to mean decline. The science is moving fast—are we ready to embrace it? ?? Dive into the science & listen to my convo with Marco here. #Longevity #Biotech #FutureOfAging #Healthspan #Innovation #RegenerativeMedicine

The future of Longevity Medicine is closer to the present. History was made again in Riyadh at the #GlobalHealthSpanSummit by Hevolution Foundation, distilling some of the most relevant Key Opinion Leaders merged from all around the world. As always, I deeply enjoyed teaming up with Rubedo Life Sciences CEO Frederick Beddingfield MD, PhD and CBO Ali Siam. Humbled to be one of the #ArchitectsOfTheFuture, as defined by Hevolution, who are working on the global mission to improve Human Health Span. Special thanks to William Greene for being a fantastic moderation of our panel. Kudos to Sophia Pathai MD, PhD for a wonderful discussion on stage on the Future of HealthSpan Medicine. Always amazing job by Mehmood Khan in chairing the Summit. Finally thanks to the entire Hevolution Foundation team for the outstanding job in organizing such a unique event.

Big day for Rubedo Life Sciences as #CEO Frederick Beddingfield MD, PhD and CSO Marco Quarta take the Hevolution Foundation #GlobalHealthspanSummit stage alongside #biotech leaders in #longevity #science

Something truly transformative is happening in Saudi Arabia this February! I'll be speaking at the #GlobalHealthspanSummit2025 of Hevolution Foundation with hundreds of experts and changemakers in the #healthspan field. I will be speaking on behalf of Rubedo Life Sciences in the panel "Entrepreneurship in Action – How to Build a Biotech": Demystifying essential elements of building a successful biotech company, including navigating funding challenges, translating scientific innovations into marketable products, and understanding the regulatory landscape, while questioning whether the current entrepreneurial ecosystem truly supports sustainable growth in the biotech sector. The panel includes a fantastic roaster of leaders in the space, friends and colleagues: ●Ann Belien, PhD, CEO, Rejuvenate Biomed, Belgium (NS) ●Robin Mansukhani, CEO, Deciduous Therapeutics, United States ●Matthew Scholz, CEO, Oisín Biotechnologies, United States Led by: Dr. William Greene, Chief Investment Officer, Hevolution Foundation, Saudi Arabia and Dr. @Lorenz Mayr, Entrepreneur-in-Residence(EiR), Hevolution Foundation, SaudiArabia Also, Rubedo CEO Frederick Beddingfield MD, PhD will be speaking in the panel: "From Molecule to Medicine: Going all the Way from Journey of Drug Discovery and Development" ? Join us in sunny #Riyadh and be part of architecting the future of healthy aging or catch it on YouTube! ghs2025.com #GHS2025 #GlobalHealthspanSummit # ?????? #?????_????????_??????_?????_?????

Whirlwind #JPM25 where heightened expectations and security were the talk of the town. #Longevity took center stage this year, w/ top tier #biopharma, #VC, and #IB w/ newly dedicated #BD teams, specialist funds, & analyst coverage. Amazing to have so much recognition of Rubedo Life Sciences' leading role in #longevity #science

Seminal moment for Rubedo Life Sciences as we transition to a #clinical stage #biotech and disclose for the first time RLS-1496 is a first-in-class GPX4 program. Huge thanks to our team for the tireless effort to get here, and Advancing Innovation in Dermatology, Inc., #BiotechShowcase, ITA - Italian Trade Agency, R42 Group, and WuXi AppTec for providing platforms this week for CEO Frederick Beddingfield MD, PhD, founder and CSO Marco Quarta, CTO Alex Laslavic, and CBO Ali Siam to start 2025 with a bang at #JPM25!

LIVE: Happening now: Incredibly proud to see CEO Frederick Beddingfield MD, PhD representing Rubedo Life Sciences on the stage of the event JPM Healthcare Conference week #IntalyOnTheMove at Italian Counsulate Innovit innovation center as an emerging leading player in Italian Pharma and Biotech innovation. Last year we opened our European headquarter in Milan, also thanks to the support and partnership of CDP Cassa Depositi e Prestiti, IAG and others. It is such a reward and personal joy seeing many years of hard work growing to the next stage of Rubedo, moving our first program into the clinic in Europe and more to come soon! On top of that after many years of science and entrepreneurship in California, returning Innovation to my beautiful and innovative country it is a true joy and meaningful satisfaction. Italy is an industry leader in Pharma, in innovation and it is one of the top global leader in manufacturing and export, as we just heard from the speech of Director General for the promotion of Italy at the Italian Ministey if Foreign affairs Mauro Battocchi and Consil General of Italy in Sam Francisco Sergio Strozzi. Ad Maiora!

I will be speaking at the Dermatology Summit on Advancing Innovation in Dermatology, Inc. on 1/12, kicking off the J.P. Morgan HealthCare Conference week. CEO Frederick Beddingfield MD, PhD and CTO Alex Laslavic will also be speaking and presenting at different panels, along with CBO Ali Siam representing with us Rubedo Life Sciences. Looking forward to engaging discussions and insightful presentations. See you there! #Dermatology #Innovation #HealthcareConference